Breast Disease
SJR0.389
GB
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.389 | Q3 | 52.4% | |
| 2024 | — | — | 0.342 | Q3 | 49.9% | |
| 2023 | — | — | 0.361 | Q3 | 54.5% | |
| 2022 | — | — | 0.304 | Q3 | 51.1% | |
| 2021 | — | — | 0.269 | Q3 | 48.1% | |
| 2020 | — | — | 0.244 | Q4 | 43.2% | |
| 2019 | — | — | 0.302 | Q3 | 52.6% | |
| 2018 | — | — | 0.345 | Q3 | 54.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
1558-1551
ISSN
0888-6008
country
coverage
1987-1996, 1998, 2000-2008, 2010-2025